Get started
Author

Kazuhiro Ezaka

Observed names: K. Ezaka, KAZUHIRO EZAKA
OpenAlex ID: A5064158926
Function and diagnostic value of Anosmin‐1 in gastric cancer progression
2015 · Mitsuro Kanda, Dai Shimizu, et al. · International Journal of Cancer · 59
PDF
Adherens junctions associated protein 1 serves as a predictor of recurrence of squamous cell carcinoma of the esophagus
2015 · HARUYOSHI TANAKA, MITSURO KANDA, et al. · International Journal of Oncology · 31
PDF
NRAGE promotes the malignant phenotype of hepatocellular carcinoma
2016 · DAI SHIMIZU, MITSURO KANDA, et al. · Oncology Letters · 27
PDF
Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
2015 · Kazuhiro Ezaka, Mitsuro Kanda, et al. · Annals of Surgical Oncology · 27
Prognostic relevance of SAMSN1 expression in gastric cancer
2016 · Mitsuro Kanda, Dai Shimizu, et al. · Oncology Letters · 20
PDF
Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma
2015 · Satoshi Sueoka, Mitsuro Kanda, et al. · Annals of Surgical Oncology · 20
Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer
2016 · Mitsuro Kanda, Dai Shimizu, et al. · Annals of Surgical Oncology · 19
Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)
2018 · Goro Nakayama, Ayako Mitsuma, et al. · The Oncologist · 18
PDF
Postoperative adalimumab maintenance therapy for Japanese patients with Crohn’s disease: a single-center, single-arm phase II trial (CCOG-1107 study)
2018 · Takahiro Asada, Goro Nakayama, et al. · Surgery Today · 14
Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma
2015 · YURI TANAKA, MITSURO KANDA, et al. · International Journal of Oncology · 14
PDF
Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus
2015 · H. Oya, M. Kanda, et al. · Diseases of the Esophagus · 3
PDF
Phase II trial of oral S-1 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard chemotherapies (CCOG-1105 study).
2018 · Kazuhiro Ezaka, Goro Nakayama, et al. · Journal of Clinical Oncology · 2
Recurrent Acute Appendicitis During the First Stage of Labor
2016 · Yoshinori Moriyama, Tomomi Kotani, et al. · Journal of Clinical Gynecology and Obstetrics · 1
PDF
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo)
2025 · Norifumi Hattori, Goro Nakayama, et al. · Japanese Journal of Clinical Oncology
PDF
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (RINDO study).
2025 · Masashi Hattori, Norifumi Hattori, et al. · Journal of Clinical Oncology
Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer
2017 · Y. Sunagawa, G. Nakayama, et al. · Annals of Oncology
Works count: 16
Citation count: 255
H-index: 10
I10-index: 10
Year
Topic
Type